SCHEMBL19744921

SCHEMBL19744921

Cc1noc(CSc2[c]cccc2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 10/20 0.41
▸ NPC1 O15118 8/20 0.41
▸ RAB9A P51151 8/20 0.41
▸ MAPT P10636 5/20 0.41
▸ TSHR P16473 5/20 0.41
▸ TDP1 Q9NUW8 3/20 0.41
▸ MAPK1 P28482 3/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ HSD17B10 Q99714 2/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ RECQL P46063 1/20 0.38
▸ KDM1A O60341 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19746967 0.77 L3MBTL1 (0.39) SMN1; SMN2NPC1RAB9AMAPTTSHR
SCHEMBL2069336 0.76 NPC1 (0.64) SMN1; SMN2NPC1RAB9AMAPTTSHR
SCHEMBL19747206 0.73 ALDH1A1 (0.52) SMN1; SMN2RAB9AMAPTTSHRMAPK1
SCHEMBL9334108 0.68 TSHR (0.31) TSHR
SCHEMBL8995181 0.68 — —
SCHEMBL2069238 0.67 TDP1 (0.50) SMN1; SMN2NPC1RAB9AMAPTTSHR
SCHEMBL4302 0.67 POLB (0.44) SMN1; SMN2NPC1RAB9ATDP1HSD17B10
SCHEMBL192919 0.66 — —
SCHEMBL853618 0.65 ACHE (0.43) SMN1; SMN2NPC1RAB9AMAPTL3MBTL1
SCHEMBL10094741 0.64 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3471729-A1 THERAPEUTIC COMPOUNDS Rutgers, the State University of New Jersey (US) 2019-04-24 — — EP claimed
WO-2017222930-A1 THERAPEUTIC COMPOUNDS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2017-12-28 — — WO claimed
EP-3471729-A1 THERAPEUTIC COMPOUNDS Rutgers, the State University of New Jersey (US) 2019-04-24 — — EP disclosed
WO-2017222930-A1 THERAPEUTIC COMPOUNDS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2017-12-28 — — WO disclosed
Send feedback